W Michael Bonney
Affiliations
- Director at Alnylam Pharmaceuticals Inc. (ALNY), 2025-05-19
- Director at Bristol Myers Squibb Co (BMY), 2021-06-14
- Director at Magenta Therapeutics Inc. (MGTA), 2021-06-03
- Director at Kaleido Biosciences Inc. (KLDO), 2020-07-01
- Director at Sarepta Therapeutics Inc. (SRPT), 2020-02-29
- at Celgene Corp (CELG), 2019-11-22
- Director at Syros Pharmaceuticals Inc. (SYRS), 2019-06-12
- Director at Global Blood Therapeutics Inc. (GBT), 2016-06-18
- Director at Tekla World Healthcare Fund (THW), 2015-08-18
- Director at Nps Pharmaceuticals Inc (NPSP), 2015-02-25
- Chief Executive Officer at Cubist Pharmaceuticals Inc (CBST), 2015-01-21
- Director at Tekla Healthcare Opportunities Fund (THQ), 2014-07-29
- Director at H&Q Life Sciences Investors (HQL), 2014-06-30
- Director at H&Q Healthcare Investors (HQH), 2014-06-30
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| BMY | $58.90 | 88 | $5,183.20 | 7,189 | 2019-12-04 | Filing |
| SRPT | $86.74 | 2,000 | $173,480.00 | 7,051 | 2019-09-09 | Filing |
| KLDO | $14.65 | 2,555 | $37,430.75 | 1,008,523 | 2019-02-28 | Filing |
| KLDO | $13.95 | 68,965 | $962,061.75 | 1,005,968 | 2019-02-28 | Filing |
| ALNY | $58.36 | 2,000 | $116,720.00 | 4,000 | 2016-03-09 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ALNY | $283.83 | 1,617 | $458,953.11 | 16,804 | 2025-05-15 | Filing |
| ALNY | $282.81 | 1,728 | $488,695.68 | 18,421 | 2025-05-15 | Filing |
| ALNY | $282.03 | 802 | $226,188.06 | 20,149 | 2025-05-15 | Filing |
| ALNY | $281.10 | 372 | $104,569.20 | 20,951 | 2025-05-15 | Filing |
| ALNY | $280.03 | 432 | $120,972.96 | 21,323 | 2025-05-15 | Filing |